Senores Pharmaceuticals Ltd. share price target

Name: Latest research reports of Senores Pharmaceuticals Ltd. authored by KRChoksey and published by - Trendlyne research reports.
Item: Senores Pharmaceuticals Ltd.
Rating: 3
Author: KRChoksey

There are 2 reports from 2 analysts covering Senores Pharmaceuticals Ltd. available on trendlyne.com.

Reco - This broker has downgraded this stock from it's previous report.
(eg. - Buy->Hold)

Target - Broker has maintained previous recommendation but reduced share price target.

Reco - This broker has upgraded this stock from it's previous report.
(eg. - Sell->Hold)

Target - Broker has maintained previous recommendation but increased share price target.

Click on any table column to sort reports by date, stock name, broker, price, target, upside or recommendation.

Summary	Date	Stock	Author	LTP	Target	Price at reco (Change since reco%)	Upside(%)	Type	Report		Discuss
	19 Dec 2024	Senores Pharmaceuticals Ltd.	KRChoksey	620.55				IPO Note	pdf post cache		Broker Report IPO Note KRChoksey Senores Pharmaceuticals focuses on generic drugs and specialty medications across various therapeutic areas, including cardiovascular, diabetes, gastroenterology, and critical care injectables. The company manufactures products at its FDA-approved facilities, with a significant presence in regulated markets like the US, UK, and Canada. pdf Copy Link Share on Share on Share on Share on Alert
	19 Dec 2024	Senores Pharmaceuticals Ltd.	SBI Securities	620.55				IPO Subscribe	pdf post cache		Broker Report Senores Pharmaceuticals Ltd IPO Note SBI Securities pdf Copy Link Share on Share on Share on Share on Alert

* Please note that subscribers can download a maximum of 300 reports a month and 70 reports everyday.

New 52W High in past week

Senores Pharmaceuticals Ltd. share price target

There are 2 reports from 2 analysts covering Senores Pharmaceuticals Ltd. available on trendlyne.com.

IPO Note

Senores Pharmaceuticals Ltd IPO Note

Advisor Screeners